IFF Advances Softgel Technology for Complex Fill Formulations

Rhea-AI Summary

IFF has successfully achieved a significant milestone in the dietary supplement industry by encapsulating high viscosity liquid and semi-liquid ingredients using its patented SeaGel^® technology. This breakthrough allows for the development of plant-based softgels that rival traditional gelatin products. Notably, IFF has partnered with AQUANOVA AG to encapsulate NovaSOL^® Curcumin in a vegan format, addressing the growing consumer demand for plant-based alternatives. This advancement enhances encapsulation efficiency and is expected to cater to the increasing market for plant-based supplements.

Positive

• Successful encapsulation of NovaSOL® Curcumin in a vegan softgel format.
• Technical breakthrough enhances product development for high viscosity ingredients.
• Increased capability aligns with growing consumer demand for plant-based supplements.

Negative

• None.

Leading patented SeaGel^® technology achieves industry's first encapsulation success with liquid curcumin

NEW YORK, April 4, 2023 /PRNewswire/ -- IFF today announced its encapsulation success with high viscosity liquid and semi-liquid nutritional ingredients in softgel dietary supplement applications. This technical breakthrough‒a first in the industry‒allows manufacturers to develop robust, high-quality, plant-based soft-shell capsules that match the performance of traditional animal-based gelatin for complex ingredients, and meets an increasing consumer need for plant-based supplements.

IFF's latest capability to encapsulate NovaSOL^® Curcumin and NovaSOL^® Curcumin/Boswellia from AQUANOVA AG, a German-based B2B manufacturer of liquid colloidal formulations, demonstrates the company's unwavering commitment in addressing softgel technology challenges for dietary supplements. This is AQUANOVA's first successful encapsulation of their products in a vegan softgel format.

"The importance of SeaGel^® cannot be understated when supporting the delivery of ingredients of such high viscosity such as liquid curcumin," said Benjamin Roscoe, application development and innovation manager at IFF. "We are thrilled with this new breakthrough in one of the most technically challenging aspects in plant-based softgels."

Globally, SeaGel^® has been used in non-gelatin soft capsules containing a wide range of nutrient ingredients for decades. Its outstanding film strength, elasticity and performance match that of animal-derived gelatin, delivering superior encapsulation efficiency and excellent seal strength. Plant-based ingredients, however, can be difficult to deliver, especially in softgel applications due to complex development and formulation challenges.

"More and more consumers are replacing their intake of animal-based products with plant-based alternatives and we have been searching for solutions to meet this demand," said Frank Behnam, CEO of AQUANOVA AG. "Our proprietary NovaSOL^® technology significantly enhances the efficacy and application scope of natural ingredients. The ability to encapsulate NovaSOL^® in a vegan softgel using SeaGel^® is a significant milestone and we are very excited about this achievement."

For more information, please visit https://www.iff.com/portfolio/markets/pharmaceutical/plant-based-supplements/products

Welcome to IFF

At IFF (NYSE: IFF), an industry leader in food, beverage, health, biosciences and scent, science and creativity meet to create essential solutions for a better world – from global icons to unexpected innovations and experiences. With the beauty of art and the precision of science, we are an international collective of thinkers who partners with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves. Together, we will do more good for people and planet. Learn more at iff.com, Twitter , Facebook, Instagram, and LinkedIn.

©2023 International Flavors & Fragrances Inc. (IFF). IFF, the IFF Logo, and all trademarks and service marks denoted with ™, ^SM or ® are owned by IFF or affiliates of IFF unless otherwise noted. All Rights Reserved.

Contact:
Reena Chaudhary
Senior Specialist Global Communications
+91 9769820494
reena.chaudhary@iff.com

SOURCE IFF

FAQ

What is the significance of IFF's recent encapsulation breakthrough?

IFF's encapsulation breakthrough allows the development of plant-based softgels that match traditional gelatin, addressing consumer demand for vegan dietary supplements.

Who is IFF collaborating with for their encapsulation technology?

IFF is collaborating with AQUANOVA AG to encapsulate NovaSOL® Curcumin in a vegan softgel format.

How does SeaGel® technology benefit dietary supplements?

SeaGel® technology offers superior encapsulation efficiency and seal strength, making it suitable for high viscosity ingredients like liquid curcumin.

When was this encapsulation success announced?

IFF announced their encapsulation success on April 4, 2023.

What consumer trend is influencing IFF's product development?

There is an increasing consumer trend towards replacing animal-based products with plant-based alternatives, influencing IFF's development of vegan supplements.